These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29313951)

  • 21. Efficacy of oral tranexemic acid in refractory melasma: A clinico-immuno-histopathological study.
    Nagaraju D; Bhattacharjee R; Vinay K; Saikia UN; Parsad D; Kumaran MS
    Dermatol Ther; 2018 Sep; 31(5):e12704. PubMed ID: 30253023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies.
    Taraz M; Niknam S; Ehsani AH
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.
    Desai S; Chan L; Handog E; Djojoseputro L; Lim J; Ling R; Nguyen H; Tam E; Tang J; Thng S; Tran H
    J Drugs Dermatol; 2023 Apr; 22(4):386-392. PubMed ID: 37026889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation.
    Na JI; Choi SY; Yang SH; Choi HR; Kang HY; Park KC
    J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1035-9. PubMed ID: 22329442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral Tranexamic Acid for the Treatment of Melasma: A Case Series and Novel Dosing Regimen.
    Foss M; Nethers K; Bhukhan A; Nathoo R
    J Drugs Dermatol; 2022 Apr; 21(4):393-398. PubMed ID: 35389597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the efficacy of Myjet-assisted tranexamic acid and vitamin C in treating melasma: A split-face controlled trial.
    Zhao H; Li M; Zhang X; Li L; Yan Y; Wang B
    J Cosmet Dermatol; 2020 Jan; 19(1):47-54. PubMed ID: 31479196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tranexamic Acid in the Treatment of Melasma: A Review of the Literature.
    Perper M; Eber AE; Fayne R; Verne SH; Magno RJ; Cervantes J; ALharbi M; ALOmair I; Alfuraih A; Nouri K
    Am J Clin Dermatol; 2017 Jun; 18(3):373-381. PubMed ID: 28283893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial.
    Lee JH; Park JG; Lim SH; Kim JY; Ahn KY; Kim MY; Park YM
    Dermatol Surg; 2006 May; 32(5):626-31. PubMed ID: 16706756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser.
    Cho HH; Choi M; Cho S; Lee JH
    J Dermatolog Treat; 2013 Aug; 24(4):292-6. PubMed ID: 22103770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the Efficacy of Tranexamic Acid Solution 5% in the Treatment of Melasma in Patients of South Asian Descent.
    Akhtar N; Shah RR; Waqas N; Jasti S; Sharif S; Shah A; Abbasi HH; Rao B
    Cutis; 2023 Oct; 112(4):187-191.E4. PubMed ID: 37988305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic efficacy and safety of oral tranexamic acid 250 mg once a day versus 500 mg twice a day: a comparative study.
    Chowdhary B; Mahajan VK; Mehta KS; Chauhan PS; Sharma V; Sharma A; Vashist S; Kumar P
    Arch Dermatol Res; 2021 Mar; 313(2):109-117. PubMed ID: 32356007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic efficacy and safety of oral tranexamic acid and that of tranexamic acid local infiltration with microinjections in patients with melasma: a comparative study.
    Sharma R; Mahajan VK; Mehta KS; Chauhan PS; Rawat R; Shiny TN
    Clin Exp Dermatol; 2017 Oct; 42(7):728-734. PubMed ID: 28649780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the efficacy of topical hydroquinone 2% versus intradermal tranexamic acid microinjections in treating melasma: a split-face controlled trial.
    Saki N; Darayesh M; Heiran A
    J Dermatolog Treat; 2018 Jun; 29(4):405-410. PubMed ID: 29027510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review.
    Kim HJ; Moon SH; Cho SH; Lee JD; Kim HS
    Acta Derm Venereol; 2017 Jul; 97(7):776-781. PubMed ID: 28374042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of oral melatonin in recalcitrant melasma.
    Sarkar R; Verma B; Mendiratta V
    Int J Dermatol; 2024 Aug; 63(8):1111-1112. PubMed ID: 38650083
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of oral tranexamic acid on erythema index in patients with melasma.
    Nguyen J; Rajgopal Bala H; Ross A; Wong CC; Paul E; Rodrigues M
    Australas J Dermatol; 2021 May; 62(2):206-209. PubMed ID: 33125702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of melasma with oral administration of tranexamic acid.
    Wu S; Shi H; Wu H; Yan S; Guo J; Sun Y; Pan L
    Aesthetic Plast Surg; 2012 Aug; 36(4):964-70. PubMed ID: 22552446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of microneedling and oral tranexamic acid in the treatment of facial melasma in women: An open, evaluator-blinded, randomized clinical trial.
    Cassiano D; Esposito ACC; Hassun K; Bagatin E; Lima MMDA; Lima EVA; Miot LDB; Miot HA
    J Am Acad Dermatol; 2020 Oct; 83(4):1176-1178. PubMed ID: 32035945
    [No Abstract]   [Full Text] [Related]  

  • 40. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.